Pag-aaral pangklinika para sa Migraine sa Texas
13 pag-aaral para sa Migraine ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
- Austin8 pag-aaral
- Houston7 pag-aaral
- Dallas5 pag-aaral
- El Paso3 pag-aaral
- San Antonio3 pag-aaral
- Grand Prairie3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Alina Clinical Trials, LLC., Dallas
- North Texas Center for Clinical Research, Frisco
- DM Clinical Research - Cy Fair, Houston
- at 6 pa
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dell Children's Medical Center, Austin
- Houston Clinical Trials, LLC, Bellaire
- FutureSearch Trials of Dallas, LLC, Dallas
- at 5 pa
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
- Houston Clinical Trials, LLC, Bellaire
- at 4 pa
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577, Austin
- Earle Research /ID# 270424, Houston
- Clinpoint Trials /ID# 270261, Waxahachie
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dell Children's Hospital-UT Health, Austin
Nagre-recruit
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- DHR Health Headache Center, McAllen
Nagre-recruitPhase 4
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin
- Austin Regional Clinic - ARC Four Points /ID# 276301, Austin
- Velocity Clinical Research, Austin /ID# 230557, Austin
- at 13 pa
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- FutureSearch Trials of Neurology, Austin
- FutureSearch Trials of Dallas, Dallas
- SFF Medical Research Group LLC, Houston
Nagre-recruitPhase 2
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07616128A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- FutureSearch Trials of Neurology, Austin
- Tekton Research, Austin
- APD Clinical Research, Cypress
- at 7 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Road Runner Research Ltd, San Antonio
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- FutureSearch Trials, Austin
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update May 19, 2026 · NCT06602479Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
- University Medical Center of El Paso, El Paso
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update May 6, 2026 · NCT06016465Stimulation of External Carotid Artery Circulation
- University of Texas Medical Branch, Galveston
Nagre-recruit
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT07402954Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.